Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 December 2007, Vol. 110, No. 12, pp. 4022-4029.
Prepublished online as a Blood First Edition Paper on August 24, 2007; DOI 10.1182/blood-2007-04-082040.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Appendix
Right arrow All Versions of this Article:
blood-2007-04-082040v1
110/12/4022    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hagedorn, N.
Right arrow Articles by Eckert, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hagedorn, N.
Right arrow Articles by Eckert, C.
Related Collections
Right arrow Neoplasia
Right arrow Clinical Trials and Observations
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

NEOPLASIA

Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of "isolated" and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group

Nikola Hagedorn1, Cécile Acquaviva2, Eva Fronkova3, Arend von Stackelberg1, Andrea Barth1, Udo zur Stadt4, André Schrauder5, Jan Trka3, Nathalie Gaspar6, Karl Seeger1, Günter Henze1, Hélène Cavé2, and Cornelia Eckert1

1 Department of Pediatric Oncology/Hematology, Charité Medical University Berlin, Berlin, Germany; 2 Laboratoire de Biochimie Génétique–Département de Génétique, Hôpital Robert Debré, Paris, France; 3 Department of Pediatric Hematology/Oncology, 2nd Medical School, Charles University, Prague, Czech Republic; 4 Department of Pediatric Hematology/Oncology, University Medical Center Hamburg, Eppendorf, Germany; 5 Department of Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany; and 6 Service d'Hématol-immunologie pédiatrique, Hôpital Robert Debré, Paris, France

This study investigates the extent of bone marrow (BM) involvement at diagnosis of apparent isolated extramedullary (AIEM) relapses of childhood acute lymphoblastic leukemia (ALL) and its relation to prognosis. Sixty-four children with first AIEM relapse treated in Germany, Czech Republic, or France were included. Real-time quantitative polymerase chain reaction using T-cell receptor and immunoglobulin gene rearrangements provided a sensitive measure of submicroscopic BM involvement, which was detectable at a level of 10–4 or higher in 46 patients and less than 10–4 in 11 patients, and was nondetectable (sensitivity: 10–4) in 7 patients. In the total cohort, the probability of event-free survival (pEFS) for children with BM involvement of 10–4 or higher was 0.30 (0.09 ± SE) versus 0.60 (± 0.12) for those with less than 10–4 (P = .13). The cumulative incidence of subsequent relapse was 0.24 (± 0.01) for patients with BM involvement less than 10–4 and 0.65 (± 0.01) for those with 10–4 or higher (P = .012). Restricted to central nervous system (CNS) relapses, pEFS was 0.11 (± 0.09) for patients with BM involvement 10–4 or higher and 0.63 (± 0.17) for those with less than 10–4 (P = .053). CNS relapses were associated with a higher (≥ 10–4: 80%) submicroscopic BM involvement than testicular relapses (≥ 10–4: 57%, P = .08). In summary, we show marked heterogeneity of submicroscopic BM involvement at first AIEM relapse diagnosis in children with ALL, and demonstrate its possible prognostic relevance.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
NEJMHome page
C.-H. Pui, D. Campana, D. Pei, W. P. Bowman, J. T. Sandlund, S. C. Kaste, R. C. Ribeiro, J. E. Rubnitz, S. C. Raimondi, M. Onciu, et al.
Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
N. Engl. J. Med., June 25, 2009; 360(26): 2730 - 2741.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020